How do you approach adjuvant therapy for patients with advanced ovarian cancer who undergo interval debulking surgery following six cycles of neoadjuvant chemotherapy?  

How does your approach vary based on residual disease left at the time of surgery? Please specify your approach for the amount of residual disease at time of surgery.



Answer from: at Community Practice

Answer from: at Community Practice